Skip to content

A randomized controlled trial for neuroregulation of post-stroke dysfunction by transcranial combined with peripheral magnetic stimulation

A study on neuroregulation of post-stroke dysfunction by transcranial combined with peripheral magnetic stimulation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033495
Enrollment
Unknown
Registered
2020-06-02
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

1:sham stimulation
2:Transcranial magnetic stimulation on swallow function
3:peripheral magnetic stimulation
4:peripheral associated with transcranial magnetic stimulation

Sponsors

Huashan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Part I For stroke patients, the diagnosis conforms to the key points of diagnosis of various cerebrovascular diseases approved by the Fourth National Conference on cerebrovascular diseases in 1995; the age is 40-80 years old; there is no serious organ disease such as heart, liver and kidney; the vital signs are stable; there is motor dysfunction, Brunnstrom grade is 2-4; the onset time is 1 month to 12 months; the patient or the authorized client signs the informed consent. Part II For stroke patients, the diagnosis conforms to the key points of diagnosis of various cerebrovascular diseases approved by the Fourth National Conference on cerebrovascular diseases in 1995; the age is 40-80 years old; there is no serious organ disease such as heart, liver and kidney; the vital signs are stable; there is swallowing dysfunction, grade II-V of Wada drinking water test, 1-2 times / 30s of reverse salivary swallowing test; the onset time is 1 month to 12 months; the patient himself or the authorized committee The client signs the informed consent.

Exclusion criteria

Exclusion criteria: Patients with metal implants in the skull and unable to take them out, those who can't tolerate MRI examination such as claustrophobia, those who have a history of epilepsy, and those who can't cooperate with the treatment.

Design outcomes

Primary

MeasureTime frame
FMA-UE;MEP;SICI;

Countries

China

Contacts

Public ContactYulian Zhu
zyljully@163.com+86 13816783039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026